Skip to main content

Day: January 25, 2021

Parker to Announce Fiscal 2021 Second Quarter Earnings on February 4th; Conference Call and Webcast Scheduled for 11 a.m. Eastern

CLEVELAND, Jan. 25, 2021 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it will release its fiscal 2021 second quarter earnings before the market opens on Thursday, February 4, 2021, followed by a conference call at 11:00 a.m., Eastern time.  During the call, the company will discuss fiscal 2021 second quarter results and respond to questions from institutional investors and security analysts.  The conference call will be webcast simultaneously on Parker’s investor website at www.phstock.com with an accompanying slide presentation. The webcast will be archived on the site for one year and available for replay later that day.Parker Hannifin is a Fortune 250 global leader in motion and control technologies.  For more than 100 years the company...

Continue reading

Caladrius Biosciences Closes $25.0 Million Private Placement

BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has closed on its previously announced sale of an aggregate of 12,500,000 shares of its common stock and warrants to purchase up to an aggregate of 6,250,000 shares of common stock to several institutional and accredited investors, at a purchase price of $2.00 per share and associated warrant, in a private placement priced at-the-market under Nasdaq rules.H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.The warrants have an exercise price of $2.90 per share, are exercisable immediately and have a term of five and one-half years.The...

Continue reading

Monroe Capital Corporation Closes Offering of $130 Million 4.75% Notes Due 2026

CHICAGO, Jan. 25, 2021 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it has closed a public offering of $130 million aggregate principal amount of 4.75% notes due 2026 (the “Notes”).The Company intends to use the net proceeds from this offering to redeem all of its outstanding 5.75% notes due 2023 and to repay a portion of the amount outstanding under its credit facility. However, the Company may re-borrow under its credit facility and use such borrowings to invest in lower middle-market companies in accordance with its investment objective and strategies and for working capital and general corporate purposes. As of January 12, 2021, the Company had $114.9 million in outstanding indebtedness under its credit facility.The Notes will mature on February 15, 2026, and may be redeemed...

Continue reading

Halo Collective Announces Overnight Marketed Offering of Units

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) — Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: AGEEF) (Germany: A9KN), is pleased to announce that is has entered into an agreement pursuant to which Eight Capital, on behalf of a syndicate of underwriters (collectively the “Underwriters”), has agreed to offer for sale units of the Company (the “Units”) on an overnight marketed basis (the “Offering”).The Offering is expected to be priced in the context of the market, with the final terms of the Offering to be determined at the time of pricing. There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms...

Continue reading

Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock

BRENTWOOD, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.J.P. Morgan Securities LLC and Jefferies LLC are acting as lead bookrunning managers, and Barclays Capital Inc., KKR Capital Markets LLC, and Macquarie Capital (USA) Inc. are acting...

Continue reading

Seer Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) — Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed underwritten public offering of 3,500,000 shares of Class A common stock (1,400,000 of which are being offered for sale by Seer and 2,100,000 are being offered for sale by selling stockholders of Seer). In addition, the selling stockholders of Seer expect to grant the underwriters a 30-day option to purchase up to 525,000 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Seer...

Continue reading

Covenant Logistics Group Announces Fourth Quarter Financial and Operating Results

CHATTANOOGA, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NASDAQ/GS: CVLG) (“Covenant”) announced today financial and operating results for the fourth quarter ended December 31, 2020. The Company’s live conference call to discuss the quarter will be held at 11:00 A.M. Eastern Time on Tuesday, January 26, 2021.Chairman and Chief Executive Officer, David R. Parker, commented: “During 2020 we strategically repositioned our enterprise around our Dedicated, Expedited, Managed Freight, and Warehousing business units, reduced our fixed overhead and capital deployed in non-core businesses, flattened our management structure, and improved our margins on an adjusted basis. For perspective, our revenue was approximately the same on a fleet that is nearly 18% smaller than the same quarter last year. At the same time,...

Continue reading

Ninepoint Partners Announces January 2021 Cash Distributions for ETF Series Securities

TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the January 2021 cash distributions for its ETF Series securities. The record date for the distributions is February 1, 2021 and distributions are payable on February 8, 2021.The per-unit January distributions are detailed below:About Ninepoint PartnersBased in Toronto, Ninepoint Partners LP is one of Canada’s leading alternative investment management firms overseeing approximately $7 billion in assets under management and institutional contracts. Committed to helping investors explore innovative investment solutions that have the potential to enhance returns and manage portfolio risk, Ninepoint offers a diverse set of alternative strategies including Alternative Income and Real Assets, in addition to North American and Global...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.